QGP

Innospec Reports Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Tuesday, February 13, 2024
Acquisition, Innospec, QGP, Growth, Chemical substance, GAAP, Depreciation, Optimism, Public expenditure, EPS, Corporation, Bank statement, Video game

Commenting on the fourth quarter results, Patrick S. Williams, President and Chief Executive Officer, said,

Key Points: 
  • Commenting on the fourth quarter results, Patrick S. Williams, President and Chief Executive Officer, said,
    “This was another very good quarter for Innospec.
  • Fuel Specialties achieved double-digit operating income growth in the quarter and gross margins were within our target range of 32 to 35 percent.
  • Revenues in Oilfield Services of $175.4 million for the quarter decreased 4 percent from the $183.5 million in the fourth quarter last year.
  • As of December 31, 2023, Innospec had net cash of $203.7 million compared to net cash of $147.1 million a year ago.

Innospec Acquires QGP Química

Retrieved on: 
Monday, December 11, 2023
Depreciation, Acquisition, Personal care, Home care, Bank statement, Construction, QGP, GAAP, EPS

ENGLEWOOD, Colo., Dec. 11, 2023 (GLOBE NEWSWIRE) --  Innospec Inc. (NASDAQ: IOSP) today announced that it completed the acquisition of QGP Química Geral (“QGP”), a leading specialty chemicals company based in Brazil.

Key Points: 
  • ENGLEWOOD, Colo., Dec. 11, 2023 (GLOBE NEWSWIRE) --  Innospec Inc. (NASDAQ: IOSP) today announced that it completed the acquisition of QGP Química Geral (“QGP”), a leading specialty chemicals company based in Brazil.
  • With this acquisition, Innospec now has a meaningful manufacturing, customer-service and product development base in South America which is one of the largest and most important global markets for all Innospec technologies.
  • QGP also adds new surfactant and other specialty chemistries to Innospec’s global portfolio in important growth markets like Agriculture.
  • Innospec will integrate QGP into its Performance Chemicals business.

NCKU Researchers Observe "Sequential Melting" of Upsilon Particles in Gold Nuclei Collisions

Retrieved on: 
Wednesday, April 19, 2023
Freedom, RHIC, Uranium, Lead, Research, Temperature, NCKU, Proton, Neutron, QCD, Relativistic Heavy Ion Collider, Gold, Thermodynamics, Physics, Observation, Brookhaven National Laboratory, National Cheng Kung University, Environment, Physical Review Letters, Lithium, QGP, Upsilon

TAINAN, Taiwan, April 19, 2023 /PRNewswire/ -- The strong (nuclear) interaction in particle physics is described by quantum chromodynamics (QCD), a framework in which protons and neutrons are no longer the degrees of freedom but are instead replaced by their constituents, namely quarks, and gluons, particles that mediate the strong nuclear force. The strong nuclear force, in fact, does not allow quarks to exist (and, in turn, to be observed) freely, a phenomenon commonly known as "quark confinement." However, at extremely high temperature and energy densities, such as those prevailing in the Early universe, these quarks and gluons can exist freely in the form of a "soup" known as "quark-gluon plasma" (QGP). Such a "quark deconfinement" can, in fact, be reproduced in high-energy collisions of heavy ions, such as gold, uranium, and lead.

Key Points: 
  • Such a "quark deconfinement" can, in fact, be reproduced in high-energy collisions of heavy ions, such as gold, uranium, and lead.
  • Heavy quarkonium states, such as the bottomonium or Upsilon particles, are considered to be a particularly clean (low noise) signature of sequential melting.
  • In a new study published in Physical Review Letters , researchers at RHIC belonging to the STAR Experiment Collaboration reported, for the first time, the observation of sequential melting of Upsilon states in gold nuclei collisions.
  • The results, consistent with the sequential melting pattern, showed how three distinct Upsilon states were suppressed at different levels.

Thermo Fisher Scientific and Qatar Genome Program Partner to Advance Precision Medicine

Retrieved on: 
Monday, May 23, 2022
Health, Genetics, Other Health, Clinical Trials, Pharmaceutical, Biotechnology, Diabetes, Risk, Education, Whole genome sequencing, QF, Population, Thermo Fisher Scientific, Social media, Applied Biosystems, Policy, Patheon, PPD, Health, Lists of diseases, Learning, Autism, Algorithm, Research, Culture, Fisher Scientific, Instagram, QGP, Qatar Foundation, Axiom, Technology, Organization, Standard of care, Genomics, Community development, Invitrogen, Mindful Scientific Inc., LinkedIn, Precision medicine, Twitter, Cancer, Laboratory, Pharmaceutical Services Negotiating Committee, Antibiotics, Vaccine, Science, Facebook

Under the agreement, Thermo Fisher and Qatar Genome Program will develop an Axiom* custom genotyping array for pan-Arab populations using whole genome sequencing data from 19 Arab countries.

Key Points: 
  • Under the agreement, Thermo Fisher and Qatar Genome Program will develop an Axiom* custom genotyping array for pan-Arab populations using whole genome sequencing data from 19 Arab countries.
  • Our collaboration with Thermo Fisher will not only help us advance precision medicine in Qatar but also among people of Arab identity worldwide.
  • Thermo Fisher began working with Qatar Genome Program in 2018 to establish the first microarray designed specifically for the Qatari population.
  • The Qatar Genome Program is an ambitious population-based project aimed at positioning Qatar among the pioneering countries in the implementation of precision medicine.